Rapid acting insulin analogue effective in a range of body types launched

摘要

New rapid acting insulin analogue insulin glulisine has been launched by Aventis Pharma this week.Aventis Pharma says that insulin glulisine (Apidra) has a faster onset of action in people with body mass indices ranging from lean to obese,compared with rapid acting insulin analogue,insulin lispro.